143 related articles for article (PubMed ID: 12059879)
1. Effects of antiepileptic drugs on visual function, with special reference to Vigabatrin.
Sorri I
Acta Ophthalmol Scand; 2002 Jun; 80(3):343-4. PubMed ID: 12059879
[No Abstract] [Full Text] [Related]
2. Visual dysfunction in patients receiving vigabatrin: clinical and electrophysiologic findings.
Miller NR; Johnson MA; Paul SR; Girkin CA; Perry JD; Endres M; Krauss GL
Neurology; 1999 Dec; 53(9):2082-7. PubMed ID: 10599785
[TBL] [Abstract][Full Text] [Related]
3. Vigabatrin: an antiepileptic drug with major benefits but significant adverse effects.
Besag FM
Curr Drug Saf; 2010 Jul; 5(3):188-90. PubMed ID: 20624131
[No Abstract] [Full Text] [Related]
4. Visual function loss from vigabatrin: effect of stopping the drug.
Johnson MA; Krauss GL; Miller NR; Medura M; Paul SR
Neurology; 2000 Jul; 55(1):40-5. PubMed ID: 10891902
[TBL] [Abstract][Full Text] [Related]
5. Screening of patients taking vigabatrin.
Rebolleda G; Muñoz-Negrete FJ; Gutierrez C
Ophthalmology; 2000 Jul; 107(7):1219-20. PubMed ID: 10889083
[No Abstract] [Full Text] [Related]
6. Visual function is stable in patients who continue long-term vigabatrin therapy: implications for clinical decision making.
Paul SR; Krauss GL; Miller NR; Medura MT; Miller TA; Johnson MA
Epilepsia; 2001 Apr; 42(4):525-30. PubMed ID: 11440348
[TBL] [Abstract][Full Text] [Related]
7. Color vision in epilepsy patients treated with vigabatrin or carbamazepine monotherapy.
Nousiainen I; Kälviäinen R; Mäntyjärvi M
Ophthalmology; 2000 May; 107(5):884-8. PubMed ID: 10811079
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin and epilepsy: further lessons in early childhood.
Parisi P; Bombardieri R; Curatolo P
Epilepsia; 2008 Jan; 49(1):177-8. PubMed ID: 18184225
[No Abstract] [Full Text] [Related]
9. Visual field constriction on vigabatrin.
Prescrire Int; 2000 Feb; 9(45):210-1. PubMed ID: 11503799
[TBL] [Abstract][Full Text] [Related]
10. [Influence of vigabatrin on visual fields and electrophysiological tests in patients with epilepsy].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):326-8. PubMed ID: 14746191
[TBL] [Abstract][Full Text] [Related]
11. Visual field defects associated with vigabratin monotherapy in children.
Luchetti A; Amadi A; Gobbi G
J Neurol Neurosurg Psychiatry; 2000 Oct; 69(4):566. PubMed ID: 11183043
[No Abstract] [Full Text] [Related]
12. A controlled study of vigabatrin and visual abnormalities.
Manuchehri K; Goodman S; Siviter L; Nightingale S
Br J Ophthalmol; 2000 May; 84(5):499-505. PubMed ID: 10781514
[TBL] [Abstract][Full Text] [Related]
13. Epilepsy: Vigabatrin treatment and visual field loss.
Chiron C; Dulac O
Nat Rev Neurol; 2011 Apr; 7(4):189-90. PubMed ID: 21364521
[No Abstract] [Full Text] [Related]
14. Are vigabatrin-associated visual field constrictions asymptomatic?
Schmidt T; Rüther K; Schmitz B
J Neurol; 2004 Jul; 251(7):887-8. PubMed ID: 15258797
[No Abstract] [Full Text] [Related]
15. Patients treated with vigabatrin exhibit central visual function loss.
Hilton EJ; Cubbidge RP; Hosking SL; Betts T; Comaish IF
Epilepsia; 2002 Nov; 43(11):1351-9. PubMed ID: 12423385
[TBL] [Abstract][Full Text] [Related]
16. [Changes in visual field of a child treatment with vigabatrin for 2 years].
Mrugacz M; Bakunowicz-Łazarczyk A
Klin Oczna; 2003; 105(5):313-4. PubMed ID: 14746187
[TBL] [Abstract][Full Text] [Related]
17. Binasal visual field defects are not specific to vigabatrin.
Gonzalez P; Sills GJ; Parks S; Kelly K; Stephen LJ; Keating D; Dutton GN; Brodie MJ
Epilepsy Behav; 2009 Nov; 16(3):521-6. PubMed ID: 19815465
[TBL] [Abstract][Full Text] [Related]
18. Visual field defect associated with vigabatrin. Many more patients may be affected than were found in study.
Comaish IF; Gorman C; Galloway NR
BMJ; 2000 May; 320(7246):1403; author reply 1404. PubMed ID: 10858054
[No Abstract] [Full Text] [Related]
19. Vigabatrin-induced visual dysfunction in Chinese patients with refractory epilepsy.
Hui AC; Liu DT; Wong KK; Man BL; Leung T; Lam PT; Lam DS
Eur J Ophthalmol; 2008; 18(4):624-7. PubMed ID: 18609486
[TBL] [Abstract][Full Text] [Related]
20. Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy.
Clayton LM; Duncan JS; Sisodiya SM; Acheson JF
Eye (Lond); 2010 Jan; 24(1):185-6. PubMed ID: 19373265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
